Art Pappas

Art Pappas

Chief Executive Officer at
Pappas Capital LLC
78 year
Health Technology
Finance
Commercial Services

Profile

Art M.
Pappas
founded Pappas Capital Management in 1994, CoLucid Pharmaceuticals, Inc. in 2005, where he worked as Chairman, and Pappas Capital LLC in 1994, where he is working as Managing Partner from 1994.
Mr. Pappas also currently works at MUSC Foundation for Research Development, as Director, Real Endpoints LLC, as Director, OrphoMed, Inc., as Director, and various other companies.
Mr. Pappas also formerly worked at Merrell Dow USA, as Chief Executive Officer-Brazil Region, Glaxo Far East Pte Ltd., as Chief Executive Officer in 1994, Merrell Dow Pharmaceuticals Pacific Ltd., as Chief Executive Officer, and various other companies.
Mr. Pappas received his Masters Business Admin degree from Xavier University and undergraduate degree from The Ohio State University.

Art Pappas active positions

CompaniesPositionStart
Chief Executive Officer 01/04/1994
Corporate Officer/Principal 15/05/2013
Director/Board Member -
Director/Board Member -
Director/Board Member -
Director/Board Member -
Private Equity Investor -
Consultant / Advisor -
MUSC Foundation for Research Development
Director/Board Member -
░░░░ ░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ -

Former positions of Art Pappas

CompaniesPositionEnd
░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Art Pappas's experience

Training of Art Pappas

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

65

1st degree connections

42

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies42

Process Industries

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Electronic Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Consumer Services

Consumer Services

Commercial Services

Health Technology

Technology Services

Commercial Services

MUSC Foundation for Research Development

Finance

Merrell Dow USA

Glaxo Far East Pte Ltd.

Commercial Services

Technology Services

Finance

Distribution Services

Health Technology

Finance

Health Technology

Finance

Merrell Dow Pharmaceuticals Pacific Ltd.

Finance

Finance

Health Services

Health Technology

Health Technology

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!